[EN] PYRIDO PYRIMIDINES FOR USE AS DYRK1 INHIBITORS<br/>[FR] PYRIDO PYRIMIDINES UTILISÉES EN TANT QU'INHIBITEURS DE DYRK1
                        
                            
                                申请人:HOFFMANN LA ROCHE
                            
                            
                                公开号:WO2012098065A1
                            
                            
                                公开(公告)日:2012-07-26
                            
                            Compounds of formula and pharmaceutically acceptable salts thereof are described, as well as the pharmaceutical compositions containing said compounds and their pharmaceutically acceptable salts, and the use of said compounds and pharmaceutical compositions for the treatment, control or amelioration of proliferative diseases, including cancer, Down syndrome or early onset Alzheimer's disease.